EYES - Second Sight Medical Products, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
2,251
3,379
6,896
7,964
3,985
Cost of Revenue
1,421
2,152
4,888
5,117
10,076
Gross Profit
830
1,227
2,008
2,847
-6,091
Operating Expense
31,606
31,824
36,633
31,456
27,119
Operating Income
-30,776
-30,597
-34,625
-28,609
-33,210
Net Non Operating Interest Income Expense
312
362
86
93
31
Other Income Expense
-2,314
-3,357
-555
-
-
Pretax Income
-32,778
-33,592
-35,094
-28,516
-33,179
Net Income Common Stockholders
-32,778
-33,592
-35,094
-28,516
-33,179
Diluted NI Available to Com Stockholders
-32,778
-33,592
-35,094
-28,516
-33,179
Basic EPS
-
-0.0182
-0.0042
-0.0042
-0.0067
Diluted EPS
-
-0.0182
-0.0042
-0.0042
-0.0067
Basic Average Shares
-
1,839
8,297
6,769
4,944
Diluted Average Shares
-
1,839
8,297
6,769
4,944
Total Operating Income as Reported
-33,090
-33,954
-35,180
-28,609
-33,210
Total Expenses
33,027
33,976
41,521
36,573
37,195
Net Income from Continuing & Discontinued Operation
-32,778
-33,592
-35,094
-28,516
-33,179
Normalized Income
-30,464
-30,235
-34,539
-28,516
-33,179
Interest Income
312
362
86
93
31
Interest Expense
-
-
-
-
0
Net Interest Income
312
362
86
93
31
EBIT
-30,776
-30,597
-34,625
-28,609
-33,179
EBITDA
-30,372
-
-
-
-
Reconciled Cost of Revenue
1,421
2,152
4,888
5,117
10,076
Reconciled Depreciation
404
397
435
457
432
Net Income from Continuing Operation Net Minority Interest
-32,778
-33,592
-35,094
-28,516
-33,179
Total Unusual Items Excluding Goodwill
-2,314
-3,357
-555
-
0
Total Unusual Items
-2,314
-3,357
-555
-
0
Normalized EBITDA
-28,058
-26,843
-33,635
-28,152
-32,747
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0